Ignite Creation Date:
2024-10-25 @ 8:00 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06549608
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-08-08
Brief Title:
A Retrospective Cohort Study of Mavacamten Patient Support Program in Canada
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Patient Characteristics and Treatment Duration of Mavacamten Obstructive HCM Patient Support Program in Canada A Retrospective Cohort Study
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This real-world study will describe the demographic and clinical characteristics and mavacamten treatment of adult patients with obstructive hypertrophic cardiomyopathy who participated in the Bristol-Myers Squibb BMS-sponsored CAMZYOS Patient Support Program in Canada
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None